Page 211 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 211

References     3


                      62. Helliwell TR, Coakley JH, Wagenmakers AJ, et al. Necrotizing     82. Petersen AM, Pedersen BK. The anti-inflammatory effect of
                        myopathy in critically-ill patients. J Pathol. 1991;164(4):307-314.    exercise. J Appl Physiol. 2005;98(4):1154-1162.
                      63. Lacomis D. Critical illness myopathy.  Curr Rheumatol Rep.     83. Schweickert WD, Pohlman MC, Pohlman AS, et al. Early
                        2002;4(5):403-408.                                      physical and occupational therapy in mechanically ventilated,
                      64. Winkelman C. Inactivity and inflammation: selected cytokines   critically ill patients: a randomised controlled trial.  Lancet.
                        as biologic mediators in muscle dysfunction during critical ill-  2009;373(9678):1874-1882.
                        ness. AACN Clin Issues. 2004;15(1):74-82.            84. Thomsen GE, Snow GL, Rodriguez L, Hopkins RO. Patients
                      65. Kress  JP,  Hall  JB.  ICU-acquired  weakness  and  recovery  from   with respiratory failure increase ambulation after transfer to an
                        critical illness. N Engl J Med. 2014;370:1626-1635.     intensive care unit where early activity is a priority. Crit Care
                                                                                Med. 2008;36(4):1119-1124.
                      66. Allen DC, Arunachalam R, Mills KR. Critical illness myopathy:
                        further evidence from muscle-fiber excitability studies of an     85. Morris PE. Moving our critically ill patients: mobility barriers
                        acquired channelopathy. Muscle Nerve. 2008;37(1):14-22.  and benefits. Crit Care Clin. 2007;23(1):1-20.
                      67. Levine S, Budak  MT, Dierov  J, Singhal  S. Inactivity-induced     86. Jackson JC, Girard TD, Gordon SM, et al. Long-term cognitive
                        diaphragm dysfunction and mitochondria-targeted antioxi-  and psychological outcomes in the awakening and breathing
                        dants: new concepts in critical care medicine. Crit Care Med.   controlled trial. Am J Respir Crit Care Med. 2010;182(2):183-191.
                        2011;39(7):1844-1845.                                87. Ehlenbach WJ, Hough CL, Crane PK, et al. Association between
                      68. Hussain SN, Mofarrahi M, Sigala I, et al. Mechanical ventila-  acute care and critical illness hospitalization and cognitive func-
                        tion-induced diaphragm disuse in humans triggers autophagy.   tion in older adults. JAMA. 2010;303(8):763-770.
                        Am J Respir Crit Care Med. 2010;182(11):1377-1386.    88. Mikkelsen ME, Christie JD, Lanken PN, et al. The ARDS
                      69. Picard M, Jung B, Liang F, et al. Mitochondrial dysfunction and   Cognitive Outcomes Study (ACOS): long-term neuropsycho-
                        lipid accumulation in the human diaphragm during mechanical   logical function in acute lung injury survivors. Am J Respir Crit
                        ventilation. Am J Respir Crit Care Med. 2012;186(11):1140-1149.  Care Med. 2012;185(12):1307-1315.
                      70. Batt J, Dos Santos CC, Cameron JI, Herridge MS. Intensive-    89. Chelluri  L,  Im  KA,  Belle  SH,  et  al.  Long-term  mortality  and
                        care unit acquired weakness (ICUAW): clinical phenotypes and   quality of life after prolonged mechanical ventilation. Crit Care
                        molecular mechanisms. Am J Respir Crit Care Med. 2013;187(3):   Med. 2004;32(1):61-69.
                        238-246.                                             90. Azoulay E, Pochard F, Kentish-Barnes N, et al. Risk of post-
                                                                                traumatic stress symptoms in family members of intensive care
                      71. de Letter MA, Schmitz PI, Visser LH, et al. Risk factors for the   unit patients. Am J Respir Crit Care Med. 2005;171:987-994.
                        development of polyneuropathy and myopathy in critically ill
                        patients. Crit Care Med. 2001;29(12):2281-2286.      91. Van P, Schulz R, Chelluri L, Pinsky MR. Patient-specific, time-
                                                                                varying predictors of post-ICU informal caregiver burden:
                      72. Hough CL. Neuromuscular sequelae in survivors of acute lung   the caregiver outcomes after ICU discharge project.  Chest.
                        injury. Clin Chest Med. 2006;27(4):691-703.
                                                                                2010;137(1):88-94.
                      73. Latronico N, Peli E, Botteri M. Critical illness myopathy and     92. Douglas SL, Daly BJ, Kelley CG, O'Toole E, Montenegro H.
                        neuropathy. Curr Opin Crit Care. 2005;11(2):126-132.
                                                                                Impact of a disease management program upon caregivers of
                      74. Barnato AE, Albert SM, Angus DC, Lave JR, Degenholtz HB.   chronically critically ill patients. Chest. 2005;128(6):3925-3936.
                        Disability among elderly survivors of mechanical ventilation.     93. Pochard F, Darmon M, Fassier T, et al. Symptoms of anxiety and
                        Am J Respir Crit Care Med. 2011;183(8):1037-1042.
                                                                                depression in family members of intensive care unit patients
                      75. Chelluri  L,  Im  KA,  Belle  SH,  et  al.  Long-term  mortality  and   before discharge or death. A prospective multicenter study.  J
                        quality of life after prolonged mechanical ventilation. Crit Care   Crit Care. 2005;20(1):90-96.
                        Med. 2004;32(1):61-69.
                                                                             94. Foster M, Chaboyer W. Family carers of ICU survivors: a survey of
                      76. Dutta C, Hadley EC. The significance of sarcopenia in old age.   the burden they experience. Scand J Caring Sci. 2003;17(3):205-214.
                        J Gerontol A Biol Sci Med Sci. 1995;50 Spec No:1-4.
                                                                             95. Choi J, Sherwood PR, Schulz R, et al. Patterns of depressive symp-
                      77. Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The   toms in caregivers of mechanically ventilated critically ill adults
                        healthcare costs of sarcopenia in the United States. J Am Geriatr   from intensive care unit admission to 2 months postintensive care
                        Soc. 2004;52(1):80-85.                                  unit discharge: a pilot study. Crit Care Med. 2012;40(5):1546-1553.
                      78. Cheung AM, Tansey CM, Tomlinson G, et al. Two-year outcomes,     96. Choi J, Donahoe MP, Zullo TG, Hoffman LA. Caregivers of the
                        health care use, and costs of survivors of acute respiratory distress   chronically critically ill after discharge from the intensive care
                        syndrome. Am J Respir Crit Care Med. 2006;174(5):538-544.  unit: six months’ experience. Am J Crit Care. 2011;20(1):12-22.
                      79. Visser M, Pahor M, Taaffe DR, et al. Relationship of interleu-    97. Schelling G, Stoll C, Vogelmeier C, et al. Pulmonary function
                        kin-6 and tumor necrosis factor-alpha with muscle mass and   and health-related quality of life in a sample of long-term sur-
                        muscle strength in elderly men and women: the Health ABC   vivors of the acute respiratory distress syndrome. Intensive Care
                        Study. J Gerontol A Biol Sci Med Sci. 2002;57(5):M326-M332.  Med. 2000;26(9):1304-1311.
                      80. Giresi  PG, Stevenson  EJ, Theilhaber J, et  al. Identification     98. Neff TA, Stocker R, Frey HR, Stein S, Russi EW. Long-term
                        of a molecular signature of sarcopenia.  Physiol Genomics.   assessment of lung function in survivors of severe ARDS. Chest.
                        2005;21(2):253-263.                                     2003;123(3):845-853.
                      81. Roth SM, Metter EJ, Ling S, Ferrucci L. Inflammatory factors       99. Wilcox ME, Herridge MS. Long-term outcomes in patients
                        in age-related muscle wasting.  Curr Opin Rheumatol. 2006;   surviving acute respiratory distress syndrome. Semin Respir Crit
                        18(6):625-630.                                          Care Med. 2010;31(1):55-65.









            Section01-O-ref.indd   3                                                                                   12/10/2014   8:06:43 PM
   206   207   208   209   210   211   212   213   214   215   216